Research Article
BibTex RIS Cite

Leukemia immunophenotyping

Year 1992, Volume: 5 Issue: 4, 165 - 176, 01.12.1992

Abstract

Immunophenotyping is, by definition, to classify and subclassify the cells by using monoclonal antibodies (Mabs) raised against cell surface antigens. These antigens may be helpful to discriminate morphologically indistinguishable cells. Immunophenotyping has been used in clinical practice for many years and it became an indispensable diagnostic aid for certain diseases.

References

  • Qreaves MF. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia. Cancer Res 1981; 41: 4752 - 4766.
Year 1992, Volume: 5 Issue: 4, 165 - 176, 01.12.1992

Abstract

References

  • Qreaves MF. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia. Cancer Res 1981; 41: 4752 - 4766.
There are 1 citations in total.

Details

Subjects Clinical Sciences
Journal Section Reviews
Authors

M. Bagaran This is me

Publication Date December 1, 1992
Published in Issue Year 1992 Volume: 5 Issue: 4

Cite

APA Bagaran, M. (1992). Leukemia immunophenotyping. Marmara Medical Journal, 5(4), 165-176.
AMA Bagaran M. Leukemia immunophenotyping. Marmara Med J. December 1992;5(4):165-176.
Chicago Bagaran, M. “Leukemia Immunophenotyping”. Marmara Medical Journal 5, no. 4 (December 1992): 165-76.
EndNote Bagaran M (December 1, 1992) Leukemia immunophenotyping. Marmara Medical Journal 5 4 165–176.
IEEE M. Bagaran, “Leukemia immunophenotyping”, Marmara Med J, vol. 5, no. 4, pp. 165–176, 1992.
ISNAD Bagaran, M. “Leukemia Immunophenotyping”. Marmara Medical Journal 5/4 (December 1992), 165-176.
JAMA Bagaran M. Leukemia immunophenotyping. Marmara Med J. 1992;5:165–176.
MLA Bagaran, M. “Leukemia Immunophenotyping”. Marmara Medical Journal, vol. 5, no. 4, 1992, pp. 165-76.
Vancouver Bagaran M. Leukemia immunophenotyping. Marmara Med J. 1992;5(4):165-76.